Profiel
David L.
Guy has been Chief Commercial Officer of Favrille, Inc. since December 2005.
Previously, he served as Vice President of Global Strategic Marketing and Business Development and Oncology for Schering AG/Berlex from 2002 to 2005 and as Director of Oncology Marketing for Genentech from 2000 to 2001.
Mr. Guy was US Business Unit Head of Oncology for Sanofi-Aventis from 1994 to 2000.
He received a BS degree in Biology and Molecular Genetics from McMaster University in Hamilton, Ontario.
Eerdere bekende functies van David L. Guy
Bedrijven | Functie | Einde |
---|---|---|
Favrille, Inc. | Corporate Officer/Principal | 22-04-2009 |
Bayer Schering Pharma AG | Corporate Officer/Principal | 01-01-2005 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Verkoop & Marketing | 01-01-2001 |
SANOFI | Corporate Officer/Principal | 01-01-2000 |
Opleiding van David L. Guy
McMaster University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SANOFI | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Favrille, Inc. | Health Technology |
Bayer Schering Pharma AG | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |